Reports find Raindrop hydrogel corneal inlay can help presbyopes

Article

According to several presentations given during the American Society of Cataracts and Refractive Surgery 2014 meeting, the investigational Raindrop (ReVision Optics) transparent hydrogel corneal inlay has shown to be consistently effective for the correction of presbyopia, is relatively easy to implant, and has high patient satisfaction.

Boston-According to several presentations given during the American Society of Cataracts and Refractive Surgery 2014 meeting, the investigational Raindrop (ReVision Optics) transparent hydrogel corneal inlay has shown to be consistently effective for the correction of presbyopia, is relatively easy to implant, and has high patient satisfaction.

The Raindrop is a transparent inlay, which is about 30 µm thick and 2 mm in diameter, was designed to be placed on the stroma, beneath a 150 µm femtosecond laser-created flap. The inlay is biocompatible and has a water content similar to the cornea and the same refractive index.

Reports, such as one given by Julian Theng, FROCphth, MMed, found a low complication rate and high patient satisfaction at his practice in Singapore. 

Next: Editorial: Turning pro

Shire to submit new drug application to FDA for dry eye disease

Association update: AOA advocates on Capitol Hill, AAO launches online learning center

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
ODs reflect on their time in Minneapolis, Minnesota, citing continuing education, tech updates, and networking opportunities as valued takeaways from the meeting.
Nora Lee Cothran, OD, FAAO, discussed the importance of optometrists addressing mental health with patients in their chair.
Nora Lee Cothran, OD, FAAO, moderated an Innovation Hub panel that featured 3 companies, giving insights into what's to come in the optometric industry.
Selina McGee, OD, shares what she wants to see in future State of Dry Eye surveys and how this year's results will affect her patient care.
Marc Bloomenstein, OD, FAAO, is a clinical investigator in the trials and overviews the transformative potential of LNZ100.
Shawn Hobbs, OD, previews the annual NOA convention, which takes place in Columbus, Ohio, from July 10 to 12, 2025.
© 2025 MJH Life Sciences

All rights reserved.